{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:03:31Z","timestamp":1794258211653,"version":"4.9.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002203","name":"Brain Tumor Charity","doi-asserted-by":"publisher","award":["FL_2021_\/1_10602"],"award-info":[{"award-number":["FL_2021_\/1_10602"]}],"id":[{"id":"10.13039\/501100002203","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["MSCA-IF 890933"],"award-info":[{"award-number":["MSCA-IF 890933"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["ALTF 654-2019"],"award-info":[{"award-number":["ALTF 654-2019"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Cancer Research Foundation Switzerland","doi-asserted-by":"publisher","award":["KFS-5280-02-2021"],"award-info":[{"award-number":["KFS-5280-02-2021"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009729","name":"Ludwig Institute for Cancer Research Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006390","name":"Universit\u00e9 de Lausanne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.celrep.2025.116151","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:14:24Z","timestamp":1756743264000},"page":"116151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cancer cell and microenvironmental rewiring by ADAR1 loss impairs glioblastoma tumor growth and extends survival"],"prefix":"10.1016","volume":"44","author":[{"given":"\u00c1ngel F.","family":"\u00c1lvarez-Prado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Hern\u00e1ndez-Barranco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Rentsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catia F.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna A.","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2025.116151_bib1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.116151_bib2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMra0708126","article-title":"Malignant Gliomas in Adults","volume":"359","author":"Wen","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.116151_bib3","series-title":"Current Understanding and Treatment of Gliomas Cancer Treatment and Research","first-page":"1","article-title":"Epidemiology of Gliomas","author":"Ostrom","year":"2015"},{"key":"10.1016\/j.celrep.2025.116151_bib4","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116151_bib5","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.116151_bib6","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1073\/pnas.1219747110","article-title":"Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics","volume":"110","author":"Sottoriva","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.116151_bib7","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The Somatic Genomic Landscape of Glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116151_bib8","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cell.2015.12.028","article-title":"Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma","volume":"164","author":"Ceccarelli","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116151_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2025.116151_bib10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","article-title":"Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment","volume":"32","author":"Wang","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2025.116151_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2025.116151_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: New Dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2025.116151_bib13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2025.116151_bib14","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The Microenvironmental Landscape of Brain Tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2025.116151_bib15","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.3337","article-title":"CSF-1R inhibition alters macrophage polarization and blocks glioma progression","volume":"19","author":"Pyonteck","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116151_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad3018","article-title":"The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas","volume":"352","author":"Quail","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.116151_bib17","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1038\/onc.2017.261","article-title":"Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas","volume":"36","author":"Yan","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.celrep.2025.116151_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw7843","article-title":"Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance","volume":"12","author":"Akkari","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2025.116151_bib19","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41591-024-02893-z","article-title":"Intrathecal bivalent CAR T cells targeting EGFR and IL13R\u03b12 in recurrent glioblastoma: phase 1 trial interim results","volume":"30","author":"Bagley","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116151_bib20","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJMoa2314390","article-title":"Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma","volume":"390","author":"Choi","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.116151_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2025.116151_bib22","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/14737140.2016.1229600","article-title":"Immunological effects of chemotherapy and radiotherapy against brain tumors","volume":"16","author":"Weiss","year":"2016","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.celrep.2025.116151_bib23","article-title":"OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143","volume":"19","author":"Reardon","year":"2017","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.celrep.2025.116151_bib24","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S1470-2045(17)30517-X","article-title":"Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial","volume":"18","author":"Weller","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.celrep.2025.116151_bib25","article-title":"Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response","volume":"131","author":"Locquenghien","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2025.116151_bib26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.trecan.2019.03.004","article-title":"ADAR and Immune Silencing in Cancer","volume":"5","author":"Herbert","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.celrep.2025.116151_bib27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2025.116151_bib28","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1126\/science.aac7049","article-title":"RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself","volume":"349","author":"Liddicoat","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.celrep.2025.116151_bib29","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.celrep.2014.10.041","article-title":"The RNA-Editing Enzyme ADAR1 Controls Innate Immune Responses to RNA","volume":"9","author":"Mannion","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2025.116151_bib30","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2017.12.038","article-title":"Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown","volume":"172","author":"Chung","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116151_bib31","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.2414","article-title":"Mutations in ADAR1 cause Aicardi-Gouti\u00e8res syndrome associated with a type I interferon signature","volume":"44","author":"Rice","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2025.116151_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coi.2014.10.005","article-title":"Type I interferonopathies: Mendelian type I interferon up-regulation","volume":"32","author":"Crow","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.celrep.2025.116151_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41591-018-0302-5","article-title":"Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss","volume":"25","author":"Liu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2025.116151_bib34","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1038\/s41467-018-07824-4","article-title":"Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells","volume":"9","author":"Gannon","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116151_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41586-018-0768-9","article-title":"Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade","volume":"565","author":"Ishizuka","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116151_bib36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation characterization of the Cancer Cell Line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2025.116151_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1593\/tlo.09100","article-title":"Modeling Adult Gliomas Using RCAS\/t-va Technology","volume":"2","author":"Hambardzumyan","year":"2009","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.celrep.2025.116151_bib38","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/glia.21142","article-title":"Genetic modeling of gliomas in mice: new tools to tackle old problems","volume":"59","author":"Hambardzumyan","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.celrep.2025.116151_bib39","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1101\/gad.903001","article-title":"PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo","volume":"15","author":"Dai","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2025.116151_bib40","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1074\/jbc.M310162200","article-title":"Stress-induced Apoptosis Associated with Null Mutation of ADAR1 RNA Editing Deaminase Gene","volume":"279","author":"Wang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.celrep.2025.116151_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100522","article-title":"Protocol for mouse adult neural stem cell isolation and culture","volume":"2","author":"Ahmed","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.celrep.2025.116151_bib42","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s41556-022-00959-z","article-title":"ADAR1 downregulation by autophagy drives senescence independently of RNA editing by enhancing p16INK4a levels","volume":"24","author":"Hao","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.celrep.2025.116151_bib43","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41577-022-00829-7","article-title":"The role of galectins in immunity and infection","volume":"23","author":"Liu","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2025.116151_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.609948","article-title":"MIF-Dependent Control of Tumor Immunity","volume":"11","author":"Noe","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2025.116151_bib45","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1172\/JCI123360","article-title":"An osteopontin\/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion","volume":"128","author":"Klement","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2025.116151_bib46","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.stem.2014.01.005","article-title":"Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth","volume":"14","author":"Pietras","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.celrep.2025.116151_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1172\/JCI121266","article-title":"Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target","volume":"129","author":"Wei","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2025.116151_bib48","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1172\/JCI124918","article-title":"Osteopontin controls immunosuppression in the tumor microenvironment","volume":"128","author":"Shurin","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2025.116151_bib49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.stem.2016.05.004","article-title":"ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis","volume":"19","author":"Zipeto","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.celrep.2025.116151_bib50","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nri1961","article-title":"Interferons, immunity and cancer immunoediting","volume":"6","author":"Dunn","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2025.116151_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01763","article-title":"ADAR1: \u201cEditor-in-Chief\u201d of Cytoplasmic Innate Immunity","volume":"10","author":"Lamers","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2025.116151_bib52","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cell.2013.03.024","article-title":"ADAR1 Forms a Complex with Dicer to Promote MicroRNA Processing and RNA-Induced Gene Silencing","volume":"153","author":"Ota","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2025.116151_bib53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nsmb1041","article-title":"Modulation of microRNA processing and expression through RNA editing by ADAR deaminases","volume":"13","author":"Yang","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2025.116151_bib54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13059-021-02271-9","article-title":"ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism","volume":"22","author":"Tassinari","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.celrep.2025.116151_bib55","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143397","article-title":"ADAR1-mediated RNA editing links ganglioside catabolism to glioblastoma stem cell maintenance","volume":"132","author":"Jiang","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2025.116151_bib56","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111003119","article-title":"STING activation promotes robust immune response and NK cell\u2013mediated tumor regression in glioblastoma models","volume":"119","author":"Berger","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.celrep.2025.116151_bib58","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The Genotype-Tissue Expression (GTEx) project","volume":"45","author":"Lonsdale","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.celrep.2025.116151_bib59","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/s41467-018-03731-w","article-title":"Somatic genome editing with the RCAS-TVA-CRISPR-Cas9 system for precision tumor modeling","volume":"9","author":"Oldrini","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116151_bib60","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2025.116151_bib61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2025.116151_bib62","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/bioinformatics\/btt287","article-title":"REDItools: high-throughput RNA editing detection made easy","volume":"29","author":"Picardi","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.celrep.2025.116151_bib57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.celrep.2025.116151_bib63","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.116151_bib64","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","article-title":"Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells","volume":"181","author":"Klemm","year":"2020","journal-title":"Cell"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725009222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725009222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:37:30Z","timestamp":1790138250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124725009222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2211124725009222"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116151","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer cell and microenvironmental rewiring by ADAR1 loss impairs glioblastoma tumor growth and extends survival","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116151"}}